Literature DB >> 18608461

D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole.

Tushar Nahata1, Tulsi Ram Saini.   

Abstract

This work was aimed to design and optimize a long acting microsphere-based injectable formulation of aripiprazole by using D-optimal experimental design methodology. Microspheres were prepared by solvent evaporation method using PLGA and cholesterol as release rate retardant materials. The microspheres were characterized for their encapsulation efficiency, particle size, surface morphology, residual solvent content, and drug release behavior. Contour plots were plotted to study the encapsulation and release behaviour of the drug from the microspheres. Desirability technique was used for the optimization of microsphere formulation composition. By using an optimum blend of drug and cholesterol in the microsphere formulation it was possible to attain a consistent drug release for a period of 14 days. The results have confirmed that the D-optimal experimental design technique can be successfully employed for designing the long acting microsphere dosage form.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608461     DOI: 10.1080/03639040701836545

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  4 in total

1.  Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.

Authors:  Chiara Rapinesi; Georgios D Kotzalidis; Lorenzo Mazzarini; Roberto Brugnoli; Stefano Ferracuti; Sergio De Filippis; Ilaria Cuomo; Gloria Giordano; Antonio Del Casale; Gloria Angeletti; Gabriele Sani; Paolo Girardi
Journal:  Clin Drug Investig       Date:  2019-08       Impact factor: 2.859

2.  A Modified Particle Swarm Optimization Technique for Finding Optimal Designs for Mixture Models.

Authors:  Weng Kee Wong; Ray-Bing Chen; Chien-Chih Huang; Weichung Wang
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

3.  Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies.

Authors:  Yu-Tsai Yang; Anthony J Di Pasqua; Yong Zhang; Katsuhiko Sueda; Michael Jay
Journal:  Pharm Dev Technol       Date:  2013-09-19       Impact factor: 3.133

4.  Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers.

Authors:  Enas El-Maghawry; Mina I Tadros; Seham A Elkheshen; Ahmed Abd-Elbary
Journal:  Int J Nanomedicine       Date:  2020-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.